Principia Biopharma

📍 South San Francisco, United States🗓 Founded 2008👥 21 employees💰 Last funded Aug 2019
Biotechnology🌐 principiabio.com
Website LinkedIn
We are a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with significant unmet medical needs in immunology and oncology. Our proprietary Tailored Covalency® platform enables us to design and develop reversible and irreversible covalent small molecule inhibitors with potencies and selectivities that we believe will rival those of injectable biologics, yet maintain the convenience of a pill. Our strategy is to advance the development of our proprietary drug candidates, and for certain programs, use collaborations and partnerships as strategic tools to maximize the value of those assets.
2
Total investors
0
Early stage
0
Mid stage
1
Late stage
2008
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Principia Biopharma?
Principia Biopharma has 2 investors on record on gritt.io and 1 late-stage investors.
When did Principia Biopharma last raise funding?
The most recent investment in Principia Biopharma recorded on gritt.io was in August 2019.
When was Principia Biopharma founded?
Principia Biopharma was founded in 2008.
What industry is Principia Biopharma in?
Principia Biopharma operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Principia Biopharma based?
Principia Biopharma is headquartered in South San Francisco, United States.